Sunitinib Accord
Аналоги Sunitinib Accord
Знайдіть доступніші аналоги та дженерики для Sunitinib Accord.
Активний інгредієнт: sunitinib
Опис товару
About Sunitinib Accord
Sunitinib Accord is a cancer medicine.
What it is used for
Not specified.
How it is used
Sunitinib Accord can only be obtained with a prescription and treatment should be started by doctors who have experience in the use of cancer medicines. Sunitinib Accord is available as capsules of various strengths to be taken by mouth. For GIST and metastatic renal cell carcinoma, Sunitinib Accord is given in six-week cycles, at a dose of 50 mg once a day for four weeks, followed by a two-week ‘rest period’. The dose can be adjusted according to the patient’s response to the treatment, but should be kept within the range of 25 to 75 mg. For pancreatic neuroendocrine tumours, Sunitinib Accord is given at a dose of 37.5 mg once a day without a rest period. This dose may also be adjusted.
How it works
The active substance in Sunitinib Accord, sunitinib, is a protein kinase inhibitor. This means that it blocks some specific enzymes known as protein kinases. These enzymes can be found at the surface of cancer cells, where they are involved in the growth and spread of cancer cells, and in the blood vessels that supply the tumours, where they are involved in the development of new blood vessels. By blocking these enzymes, Sunitinib Accord can reduce the growth and spread of the cancer and cut off the blood supply that keeps cancer cells growing.
Active substance: sunitinib
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.
